All lobbying filings

INVARIANT LLC

INVARIANT LLC filed a Q2 report for BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. on July 19, 2026, reporting $60,000 in lobbying income.

Lobbying for BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. · Animal health and veterinary medicine company

All filings by INVARIANT LLC · Everything BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Agriculture

Advocate on issues related to transboundary animal disease monitoring, control, and prevention, including as it relates to avian influenza in animal agriculture. Monitor Administration's policy related to New World Screwworm. Educate Members of Congress and the Administration on Boehringer's capabilities to address emerging animal diseases. Monitor animal health-related provisions in H.R. 7567, the Farm, Food, and National Security Act of 2026, and educate Members on Boehringer's priorities, including on animal disease prevention and response.

Bills named in this filing 1

H.R. 7567
Farm, Food, and National Security Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.